Drugs / TG1042
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00394693 | Nov 2006 → Jan 2010 | B-cell non-Hodgkin lymphoma | Transgene | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TG1042 | “repeated intra-lesional administrations of TG1042 (adenovirus-interferon-γ) in patients with relapsing primary cutaneous B-cell lymphomas (CBCL).” PMID 24586226 ↗ Feb 2014 |
| Known as | Adenovirus-interferon-γ | “TG1042 (adenovirus-interferon-γ) in patients with relapsing primary cutaneous B-cell lymphomas (CBCL).” PMID 24586226 ↗ Feb 2014 |
| Route | Other | “intra-lesional injection” NCT00394693 ↗ |